TP53 and colorectal carcinoma: This enabled us to correct VAFs for the influence of copy-number states and to then quantify the proportion of the cancer cells that harbored resistance drivers by comparison against TP53 mutations, which are usually truncal in CRC (Brannon et al., 2014).